Company Information
USD
2.31
- (9%)
NASDAQ:BTAI, BIOXCEL THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 9 May 2024 GMT-4
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company’s commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
Address
555 Long Wharf Drive
12th Floor
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Richard I. Steinhart
CFO/Chief Accounting Officer/Senior VP
Dr. Peter Mueller,PhD
Chairman of the Board/Director
Dr. Vincent J. O'Neill, M.D.
Chief Medical Officer/Senior VP
Dr. Michal Votruba, M.D.,PhD
Director
Dr. Sandeep Laumas, M.D.
Director
Dr. Vimal Mehta, PhD
CEO/Co-Founder/Director/President
Dr. Frank D. Yocca, PhD
Chief Scientific Officer/Senior VP
Mr. Matthew T. Wiley
Other Executive Officer/Senior VP
Mr. Javier Rodriguez
Chief Legal Officer/Secretary/Senior VP
Ms. June Bray
Director
Mr. Michael Miller
Director
Ownership
Institution Holdings
BioXcel Corp
8,546,750 (28.131%)
FMR LLC
2,700,727 (8.889%)
FMR Inc
2,518,564 (8.290%)
BlackRock Inc
1,374,209 (4.523%)
Fidelity Management & Research Company LLC
1,327,358 (4.369%)
Vanguard Group Inc
1,089,463 (3.586%)
Fidelity Management Trust Company
997,713 (3.284%)
BlackRock Fund Advisors
726,720 (2.392%)
Vanguard Investments Australia Ltd
640,245 (2.107%)
Ameriprise Financial Inc
541,064 (1.781%)
Individual Holdings
Dr. Peter Mueller,PhD
209,795 (1.381%)
Dr. Vimal Mehta, PhD
32,222 (0.110%)
Dr. Frank D. Yocca, PhD
11,059 (0.038%)
Mr. Javier Rodriguez
5,913 (0.020%)
Mr. Richard I. Steinhart
3,063 (0.011%)
Dr. Vincent J. O'Neill, M.D.
2,802 (0.010%)
Funds Holdings
Fidelity Growth Company Commingled Pool
1,016,357 (3.345%)
Fidelity Growth Company Fund
692,819 (2.280%)
iShares Russell 2000 ETF
507,791 (1.671%)
Columbia Small Cap Value Fund I
353,226 (1.163%)
Columbia Small Cap Val I
350,926 (1.155%)
Fidelity Growth Company K6 Fund
316,746 (1.043%)
Fidelity Small Cap Index Fund
203,667 (0.670%)
Fidelity Series Growth Company Fund
193,560 (0.637%)
iShares Russell 2000 Growth ETF
166,588 (0.548%)
Columbia VP Small Cap Value Fund
138,964 (0.457%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
